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Pterygota macrocarpa and Cola gigantea are African medicinal plants used in traditional medicine for the treatment of sores,
skin infections, and other inﬂammatory conditions including pains. This study therefore aims at investigating the antimicrobial
properties of ethanol leaf and stem bark extracts of P. macrocarpa and C. gigantea using the agar diﬀusion and the micro-dilution
techniques and also determining the anti-inﬂammatory properties of the extracts of these plants in carrageenan-induced foot
edema in seven-day old chicks. The minimum inhibitory concentration of both ethanol leaf and bark extracts of P. macrocarpa
against the test organisms was from 0.125 to 2.55mg/mL and that of C. gigantea extracts was 0.125 to 2.75mg/mL. Extracts with
concentration of 50mg/mL were most active against the test organisms according to the agar diﬀusion method. All the extracts of
P. macrocarpa and C. gigantea at 30, 100, and 300mg/kg body weight except ethanol leaf extract of C. gigantea exhibited signiﬁcant
anti-inﬂammatory eﬀects (P ≤ 0.001).
1.Introduction
The search for newer antimicrobial agents from various
sources has become imperative because of the emergence
of resistance strains of microorganisms against orthodox
antibiotics especially diﬃculty to treat infections from
resistant strains of bacteria [1] and also the fact that the
number of scientists who are developing new antibacterial
agents has dwindled, even as bacteria evolve ever more
clever mechanisms of resistance to antibiotics [2]. The
recent search for new antibiotics includes various sources
such as the synthetic compounds, bioactive agents from
aquatic microorganisms, and natural products including
medicinal plants. In Africa and other developing countries,
it is estimated that 70 to 80% of people rely on traditional
healers and herbal practitioners for their health needs [3, 4]
and medicinal plants are the main source of remedies used
in this therapy. Some of these medicinal plants are used
for the management of several diﬀerent disease conditions
suchasbacterialinfections,parasiticinfections,skindiseases,
hypertension, pains, and inﬂammation such as rheumatoid
arthritis [5–8].
Several medicinal plants including their isolated com-
pounds have been found to exhibit biological activities
related to their traditional uses, for example, geraniin
and furosin isolated from Phyllanthus mellerianus (Kuntze)
Exell. have been found to possess wound healing properties
ascribed to this plant as wound healing agent [9]. Cryptole-
pine, an alkaloid from Cryptolepine sanguinolenta,h a sb e e n
shown to possess antimicrobial and antiplasmodial activities
which have gone to conﬁrm its medicinal uses as anti-
infective and antimalarial agent [10, 11].
Pterygota macrocarpa K. Schum. belongs to the family
Sterculiaceae and is known in local Asante-Twi language
as kyereye in Ghana. It is a large tree that grows in dense2 Evidence-Based Complementary and Alternative Medicine
semideciduous forests usually distributed in West Africa
f r o mS i e r r aL e o n et oC a m e r o u n .T h es o a k e dl e a v e sa r e
used to treat stomachache, pains, and disorders of digestion.
Leaf decoctions are used for the treatment of gonorrhea
and other urinary tract infections [12–14]. Traditionally, the
bark is used in the management of haemorrhoids, dropsy,
swellings, edema, gout, leprosy, and pain [15]. The seeds of
P. macrocarpa have been found to contain phytate, oxalate
and tannins [16].
Cola gigantea A.Chev.belongstothefamilySterculiaceae
and is commonly known as giant cola and local Asante-
Twi name is watapuo in Ghana. It is a large tree in
dry semideciduous forests in West Africa and the West
Indies. The nuts (mostly called kola) are often used to
treat whooping cough, asthma, malaria, and fever. Other
traditional uses include increasing the capacity for physical
exertion and for enduring fatigue without food, stimulating
a weak heart, and treating nervous debility, weakness, lack
of emotion, nervous diarrhea, depression, despondency,
brooding, anxiety, and sea sickness [12, 14, 15, 17]. Kola
nut is the name of the mature fruits of the Cola species
[18] and has a bitter ﬂavour and high caﬀeine content
[19, 20], and when the fruit is ingested, it acts as stimulants
and thus creates an ecstatic and euphoric state [20]. The
caﬀeine present acts as a bronchodilator, expanding the
bronchial air passages [21] .T h e s ef r u i t sa r ea l s oc h e w e d
in communities during traditional ceremonies and also are
known to reduce hunger pangs. The ethanol leaf extract of C.
giganteahasbeenshowntobeactiveagainstCandidaalbicans
and phytochemical screening of the leaf extract indicated
the presence of alkaloids, saponins, tannins, anthraquinones,
and cardenolides [22]. The aim of this study is to investigate
theantimicrobialandanti-inﬂammatoryactivitiesofethanol
stem bark and leaf extracts of P. macrocarpa and C. gigantea.
2.MaterialsandMethods
2.1. Plant Material and Chemicals. Stem bark and leaves of
Pterygota macrocarpa and Cola gigantea were collected in
July, 2007, from the Bobiri Forest Reserves of the Forestry
Research Institute of Ghana (FORIG) near Kubease, Ashanti
Region, Ghana, and identiﬁed and authenticated by Dr. A.
Asase, Department of Botany, University of Ghana, Ghana.
Unless stated otherwise, all the chemicals were purchased
from Sigma (Deisenhofen, Germany).
2.2. Preparation of Extracts. T h ep l a n tm a t e r i a l sw e r ea i r
dried and powdered, and 200g each of the dried powdered
material of P. macrocarpa and C. gigantea was extracted,
respectively, with 70% ethanol (1.5L) using Soxhlet appa-
ratus. The ethanol extracts obtained were evaporated to
dryness under reduced pressure and kept in a dessicator.
The yields of the stem and leaf extracts of P. macrocarpa
were 4.2 and 12.4% w/w, respectively. And the yields of C.
gigantea were 3.6 and 16.5% w/w for stem bark and leaf
extracts, respectively. Various quantities of the ethanol leaf
extract (CGLE) and ethanol stem bark extract (CGBE) of
C. gigantea and ethanol leaf extract (PMLE) and ethanol
stem bark extract (PMBE) of P. macrocarpa were dissolved
in normal saline and methanol for acute anti-inﬂammatory
and antimicrobial determinations, respectively.
2.3. Preliminary Phytochemical Screening. Phytochemical
screening was conducted on both leaf and stem bark of
P. macrocarpa and C. gigantea to ascertain the presence of
carbohydrates, tannins, sapogenetic glycosides, ﬂavonoids,
steroids, and alkaloids [23, 24]. The tannins content was
determined according to the method of Glasl [25] using
pyrogallol (Merck, Darmstadt, Germany, purity 99.5%,
HPLC) as reference compound.
2.4. Determination of Antimicrobial Activity
2.4.1. Agar Diﬀusion Method. The antimicrobial activities
of the extracts (PMLE, CGLE, PMBE, and CGBE) and
reference drugs (chloramphenicol and clotrimazole (Sigma,
Deisenhofen, Germany)) were determined using the agar
diﬀusionmethod[26].Nutrientagar(OxoidLimited,United
Kingdom) and Sabouraud agar (Oxoid Limited, United
Kingdom) media were used for both determinations of
antibacterial and antifungal activities, respectively. 0.1mL
of 18h culture of the test organisms (Escherichia coli ATCC
25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus
aureus ATCC 25923, Bacillus subtilis NCTC 10073, and
clinical fungal agent, Candida albicans, were used to seed
nutrientagarandSabouraudagarplates,respectively.Ineach
of these plates, 4 equidistant wells (10mm) were cut out
using sterile cork borer and were ﬁlled with 200µLe a c ho f
the diﬀerent concentrations of extracts and reference drugs
andallowedtodiﬀuseatroomtemperaturefor1h.Thezones
of inhibition were measured after 24h incubation at 37◦C
(forbacteria)andafter72hat30◦C(forfungi).Theactivities
of the methanol (solvent) alone were also determined.
2.5. Determination of Minimum Inhibitory Concentration
(MIC) Using Microdilution Technique. The MICs of the
extracts (PMLE, CGLE, PMBE, and CGBE) against the
test bacteria were determined using the microdilution
technique as described by Eloﬀ [27] and modiﬁed by
Agyare and Koﬀuor [26]. Test solutions (100mg/mL) of
both extracts were prepared, test solution (25–100µL) was
serially diluted with distilled water to 100µg/mL, and
50µL of an 18h old culture of one of the test bacteria
grown in nutrient broth (Oxoid Limited, United King-
dom) was added to each well in the microplates. The
covered microplates were incubated at 37◦Cf o r2 4 h .T o
indicate growth, 30µL of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT, thiazolyl blue) dis-
solved in distilled water was added to the microplate wells
and incubated at 37◦C for 30min. C. albicans was cultivated
in Sabouraud dextrose broth (Oxoid Limited, United King-
dom) and then incubated for 3 days at 30◦C. The MICs
of PMLE, CGLE, PMBE, and CGBE against the test fungus
were determined according to the guidelines described in
the National Committee for Clinical Laboratory Standards
[28] for ﬁlamentous fungi. The minimum inhibitory con-
centration of the each extract against the test organisms wasEvidence-Based Complementary and Alternative Medicine 3
Table 1: Preliminary phytochemical screening of dried leaves and stem barks of C. gigantea (CG) and P. macrocarpa ( P M ) .+ :p r e s e n c eo f
secondary metabolite; −: absence of secondary metabolites.
Secondary metabolites Alkaloids Saponins Flavonoids Steroids Carbohydrates Sapogenetic glycosides Tannins
(% w/w)
Plant material/part
CG leaf + + + + + − 1.57
CG stem bark + + − ++ − 1.02
PM leaf + + + + + + 1.45
PM stem bark + + − ++ + 1 . 1 4
detected as the minimum concentration of extracts where
there was no microbial growth, that is, nonformation of
blue color after the addition MTT to the medium [29]. The
previous experiment was repeated three times.
2.6. Determination of Acute Anti-Inﬂammatory Activity. The
carrageenan-induced inﬂammatory model in seven-day-old
chicks [30] was employed and the responsiveness of these
chicks to anti-inﬂammatory drugs/extracts was determined.
2.7. Experimental Animals. 7-days-old cockerels Gallus gal-
lus (100–120g) (Strain: Shaver 579) purchased from Darko
Farms Company Limited, Kumasi, Ghana, were maintained
in the Animal House of the Department of Pharmacology,
Kwame Nkrumah University of Science and Technology,
Kumasi, Ghana. The chicks were housed in stainless steel
cagesandfedwithnormalcommercialpoultrydiet(GAFCO,
Tema, Ghana), given water ad libitum, and maintained
under laboratory conditions (temperature 28–30◦C, relative
humidity 60–70%, and normal light-dark cycle). A day
before the experiment, the chicks were brought to the
laboratory and habituated to experimenter handling and the
apparatus to minimize the eﬀect of stress and novelty. The 7-
day-old chicks were used in experiment. All procedures and
techniques used in these studies were in accordance with the
National Institute of Health Guidelines for the Care and Use
of Laboratory Animals (NIH, Department of Health Services
publication no. 83-23, revised 1985). The protocols for the
studywereapprovedbytheDepartmentalEthicsCommittee.
2.8. Experimental Design. At the beginning of the experi-
ment the chicks (7 days old) were randomly assigned to
one of ﬁfteen groups (n = 5). The initial foot volumes
of the chicks were measured using plethysmometer (IITC
Life Science Inc., CA, USA) after which 0.01mL of 2%
carrageenan was injected into the plantar of the right foot
to induce inﬂammation. The inﬂammation produced was
measured, the increase in foot volumes was calculated, and
thosewithanincreasebetween15and40%wereselectedand
putintothirteengroupsofﬁveafterwhichtheywereinjected
intraperitoneally with either diclofenac (Sigma, purity 98%
HPLC) (10, 30 and 100mg/kg) or dexamethasone (Sigma,
purity 98% HPLC) (0.25, 0.5, and 1.0mg/kg) based on
recommended eﬀective human doses per body weight and
PMLE, CGLE (30, 100, and 300mg/kg), or PMBE and
CGBE (30, 100 and 300mg/kg) given orally based on
preliminary investigation. One group did not receive any
drug (control). Foot volumes were measured again at hourly
interval posttreatment for 4h. The percentage change in foot
volume after induction and treatment of inﬂammation was
calculated and recorded for analysis.
2.9. Statistical Analysis. GraphPad Prism Version 5.0 for
Windows (GraphPad Software, San Diego, CA, USA) was
used for all statistical analyses. Data are presented as mean
± SEM (N = 5) and analyzed by one-way ANOVA followed
by Dunnett’s multiple comparison’s test. P<0.05 was
considered statistically signiﬁcant in all analyses. The graphs
were plotted using Sigma Plot for Windows version 11.0
(Systat Software Inc., Germany).
3. Results
3.1. Preliminary Phytochemical Screening. Both the leaf and
stem bark of P. macrocarpa and C. gigantea were found to
contain tannins (with varying amounts), alkaloids, steroids,
saponins, and carbohydrate while the leaves of the two
plants contain ﬂavonoids. The stem bark and leaves of P.
macrocarpa were found to contain sapogenetic glycosides
(Table 1).
3.2. Antimicrobial Activity. The ethanol extracts (PMLE,
PMBE,CGLE,andCGBE)werefoundtobeactiveagainstthe
test bacteria (E. coli, P. aeruginosa, S. aureus, B. subtilis)w i t h
varying mean zones of inhibition and C. albicans was found
to be less susceptible to the extracts. With respect to the
agar diﬀusion method, the extracts (PMLE, CGLE, PMBE,
and CGBE) with concentrations of 50mg/mL exhibited the
highest activity against the test organisms (Table 3). The
minimum inhibitory concentration ranges of P. macrocarpa
extracts (PMLE and PMBE) against the test organisms were
from 0.125 to 2.55mg/mL and those of C. gigantea extracts
(CGLEandCGBE)werefrom0.125to2.75mg/mL(Table 2).
3.3. Anti-Inﬂammatory Activity. All the animals injected
with carrageenan exhibited acute inﬂammation which man-
ifested as increased foot volume. The control group however
showed increased inﬂammation till the fourth hour. All the
extract-treated groups except CGLE- (F3,80 = 1.80, P =
0.1545: Figure 3) treated group exhibited signiﬁcant anti-
inﬂammatory eﬀects (PMLE: F3,80 = 47.52, P<0.0001;
PMBE: F3,80 = 35.58, P<0.001; CGBE: F3,80 = 1.80,4 Evidence-Based Complementary and Alternative Medicine
Table 2: Minimum inhibitory concentrations (MICs) of ethanol leaf extract (CGLE) and ethanol stem bark extract (CGBE) of C. gigantea
and ethanol leaf extract (PMLE) and ethanol stem bark extract (PMBE) of P. macrocarpa determined by microdilution method. The
experiments were repeated three times. Reference antimicrobial agents: CPC: chloramphenicol; CTZ: clotrimazole; ND: Not determined.
Extract/MIC
(mg/mL)
S. aureus
ATCC 25923
B. subtilis
NCTC 10073
E. coli
ATCC 25922
P. aeruginosa
ATCC 27853 C. albicans
CGLE 0.250 0.125 0.175 1.55 1.55
CGBE 0.125 0.150 0.250 2.75 1.75
PMLE 0.150 0.125 1.250 1.85 1.75
PMBE 0.125 0.175 0.155 2.55 0.75
CPC 0.025 0.020 0.025 0.055 ND
CTZ ND ND ND ND 0.025
Table 3: Antimicrobial activity of ethanol leaf extract (CGLE) and ethanol stem bark extract (CGBE) of C. gigantea and ethanol leaf extract
(PMLE)andethanolstembarkextract(PMBE)ofP. macrocarpa byagardiﬀusionmethod.Activityofthemethanol(solvent)usedtodissolve
the extracts was determined. Mean zones of inhibition (plus diameter of well) are mean (mm) of 3 independent experiments, mean ± SD,
n = 4 replicates, and diameter of well/cup = 10mm. Reference antimicrobial agents: CPC: chloramphenicol (1mg/mL); CTZ: clotrimazole
(1mg/mL); ND: Not determined.
Mean zones of growth inhibition (mm)
Extract (mg/mL)
Test organisms
S. aureus B. subtilis E. coli P. aeruginosa C. albicans
ATCC 25923 NCTC 10073 ATCC 25922 ATCC 27853
CGLE
10 19.67 ±0.58 16.80 ±0.40 12.20 ±0.17 12.24 ±0.13 12.65 ±0.58
25 24.60 ±0.53 19.33 ±0.58 16.53 ±0.24 15.50 ±0.58 16.47 ±0.48
50 28.33 ±0.58 22.30 ±0.42 19.67 ±0.56 17.50 ±0.47 22.13 ±0.23
CGBE
10 16.67 ±0.58 13.33 ±0.58 12.30 ±0.58 0.0 13.67 ±0.58
25 13.00 ±0.00 17.80 ±0.35 14.12 ±0.42 0.0 18.90 ±0.48
50 18.67 ±0.58 19.50 ±0.50 18.67 ±0.58 13.47 ±0.58 21.85 ±0.23
PMLE
10 0.0 17.80 ±0.35 0.0 0.0 12.80 ±0.20
25 14.60 ±0.58 18.50 ±0.50 19.33 ±0.58 0.0 14.00 ±0.00
50 19.67 ±0.58 22.53 ±0.12 21.47 ±0.50 16.30 ±0.23 22.33 ±0.58
PMBE
10 0.0 12.33 ±0.58 11.33 ±0.58 0.0 12.80 ±0.20
25 14.50 ±0.50 14.67 ±0.58 12.67 ±0.58 0.0 15.40 ±0.36
50 17.13 ±0.23 16.73 ±0.58 15.83 ±0.29 12.3 ±1.20 18.60 ±0.58
CPC 25.67 ±0.38 31.21 ±0.38 30.67 ±0.85 22.33 ±0.38 ND
CTZ ND ND ND ND 25.60 ±0.61
Methanol 0.0 0.0 0.0 0.0 0.0
P = 0.1545:Figures1,2,and4).Similareﬀectswereobserved
after treating the animals with diclofenac (F3,80 = 79.81,
P<0.0001) and dexamethasone (F3,80 = 90.49, P<0.0001)
used as positive controls (Figure 5).
4. Discussion
The present studies indicate the antimicrobial and anti-
inﬂammatory properties of ethanol extracts of P. macrocarpa
(PMLE and PMBE) and C. gigantea (CGLE and CGBE).
These ﬁndings were similar to our previous work [27]w i t h
ethanol extract of Funtumia elastica Preuss Stapf. (Apocy-
naceae)whichconﬁrmedtheplantashavingbothantimicro-
bial and anti-inﬂammatory properties. The antibacterial and
antifungal activities of the P. macrocarpa are being reported
for the ﬁrst time. The MIC against the test bacteria is from
the 0.125 to 2.55mg/mL and the fungal agent (C. albicans)i s
from 0.75 to 1.75mg/mL. With respect to the agar diﬀusion
method, concentration of extracts from both leaves and the
stem bark of P. macrocarpa less than 25mg/mL did not
exhibit activity against S. aureus and P. aeruginosa and less
activity against E. coli at concentration of 25mg/mL butEvidence-Based Complementary and Alternative Medicine 5
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30 mg/kg PMLE
30 mg/kg PMLE
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100 mg/kg PMLE
300 mg/kg PMLE
300 mg/kg PMLE
470.3 ± 24.08 361.8 ± 10.5 ∗∗∗ 356.6 ± 8.016 ∗∗∗ 350.4 ± 15.24 ∗∗∗
Figure 1: Eﬀect of ethanol leaf extract (PMLE) of P. macrocarpa (30–300mg/kg) on carrageenan-induced paw oedema. Values are expressed
as mean ± SEM (N = 5), signiﬁcantly diﬀerent from control. ∗∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001. Control is the untreated birds.
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Control
30 mg/kg PMBE
100 mg/kg PMBE
300 mg/kg PMBE
Control
AUC values
30 mg/kg PMBE 100 mg/kg PMBE 300 mg/kg PMBE
470.3 ± 24.08 363.5 ± 15.94 ∗∗ 363.2 ± 18.15 ∗∗ 343.7 ± 10.86 ∗∗∗
Figure 2: Eﬀect of ethanol stem bark extract (PMBE) of P. macrocarpa (30–300mg/kg) on carrageenan-induced paw oedema. Values are
expressed as mean ± SEM (N = 5), signiﬁcantly diﬀerent from control. ∗∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001. Control is the untreated
birds.
the MICs for the previous test bacteria were comparable to
the MICs of the C. gigantea extracts. This observation goes
to support the assumption that size of inhibition halos of
diﬀerent extracts cannot be used for the determination of
the relative antimicrobial potency since a more diﬀusible
b u tl e s sa c t i v ee x t r a c tc o u l dg i v eab i g g e rd i a m e t e rt h a na
nondiﬀusible but more active extract [27, 31].
The antimicrobial activities exhibited by the ethanol
extracts of leaves and stem bark of C. gigantea (CGLE and
CGBE) are in line with previous antimicrobial works on
the leaves of diﬀerent species of Cola [22, 32, 33]w h e r e
diﬀerent extracts of cola were found to exhibit inhibitory
activities against certain bacteria and fungi with respect to
the leaf extract. The MIC range of both the leaf and stem
bark extracts of C. gigantea against the test bacteria is from
0.125 to 2.75mg/mL and the mean zones of inhibition of
the diﬀerent concentration (10–50mg/mL) extracts (crude)
were almost the same as those of the reference antibacterial
agent, chloramphenicol at concentration of 1000µg/mL.
However, with the agar diﬀusion technique, the leaf extracts
ofC.gigantea(10to50mg/mL)showedmoreactivityagainst
both test bacteria and fungus compared to the extracts from6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀects of ethanol leaf extract (CGLE) of C. gigantea (30–300mg/kg) on carrageenan-induced paw oedema. Values are expressed
as mean ± SEM (N = 5), signiﬁcantly diﬀerent from control. ∗P<0.05. Control is the untreated birds.
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300 mg/kg CGBE
Control
AUC values
30 mg/kg CGLE 100 mg/kg CGLE 300 mg/kg CGLE
470.3 ± 24.08 373.3 ± 16.14 ∗∗ 366.6 ± 10.44 ∗∗∗ 365.5 ± 6.734 ∗∗∗
∗∗∗
Figure 4: Eﬀects of Ethanol stem bark extract (CGBE) of C. gigantea (30–300mg/kg) on carrageenan-induced paw oedema. Values are
expressed as mean ± SEM (N = 5), signiﬁcantly diﬀerent from control. ∗∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001. Control is the untreated
birds.
the stem bark. P. aeruginosa was found to be generally
less susceptible to all extracts from P. macrocarpa and C.
gigantean, respectively (Table 3), and this was not surprising
since it has been found to be resistant to most orthodox
antibiotics [34]. The antimicrobial properties may justify the
use of these plants for the treatment of various bacterial and
fungal infections such as gonorrhea and urethral infections
and sores.
The study also establishes the anti-inﬂammatory activity
of the ethanol extracts of the leaves and stem bark of
P. macrocarpa and C. gigantean, respectively. Carrageenan-
induced oedema has been commonly used as an experi-
mental animal model for acute inﬂammation and is estab-
lished to be biphasic. The early phase (1 to 2 hours) of
the carrageenan model is chieﬂy mediated by serotonin,
histamine, and increased synthesis of prostaglandins in theEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Eﬀects of diclofenac (10mg/kg) and dexamethasone (3mg/kg) on carrageenan-induced paw oedema. Values are expressed as
mean ± SEM (N = 5), signiﬁcantly diﬀerent from control. ∗∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001. Control is the untreated birds.
damagedtissues.Thelatephaseissustainedbyprostaglandin
release and mediated by bradykinin, leukotrienes, poly-
morphonuclear cells, and prostaglandins produced by tis-
sue macrophages [35] .T h ee x t r a c t s( P M L E ,P M P E ,a n d
CGBE) inhibited the inﬂammation induced with car-
rageenan in both phases indicating the ability of these
extracts to inhibit the synthesis or release of inﬂammatory
mediators such as histamine, serotonin, bradykinin, and
leukotrienes.
In comparing the four extracts (PMLE, CGLE, PMBE,
and CGBE), only CGLE had insigniﬁcant anti-inﬂammatory
activity in the carrageenan-induced hind paw oedema.
However the CGBE had signiﬁcant activity. The reason
for this observation may be due to diﬀerent chemical
composition of the stem bark and leaves of the same
plant. Traditionally, the bark is used in the management of
haemorrhoids: dropsy, swelling, edema, gout, leprosy, and
pain [15], and hence these results may conﬁrm the medicinal
uses of the bark. The CGBE extract may have relatively
high amounts of the bioactive constituents in relation to
the leaves. Phytochemical screening of C. gigantea showed
the presence of alkaloids and this conﬁrms the ﬁndings of
Sonibare et al. [22]. Members of the cola family are closely
related to Theobroma family of South America which have
the methylxanthine alkaloids such as caﬀeine, theobromine,
and theophylline as secondary metabolites. Caﬀeine is one of
the alkaloids of genus cola and it is used as an analgesic and
anti-inﬂammatory adjuvant [36, 37].
There was no signiﬁcant diﬀerence in anti-inﬂammatory
activity between the leaf and stem bark extracts (PMLE
and PMBE) of P. macrocarpa. However, the leaves are
traditionally used as diuretics, antiﬂatulence, and a remedy
for stomach, bladder, and urinary problems [15].
Powdered dried leaves and stem bark of P. macrocarpa
and C. gigantea showed the presence of tannins and with
diﬀerent tannin contents (1.02–1.57% w/w). Amoo and
Agunbiade [38] reported on the high tannin content of
the seeds of P. macrocarpa. Similar results were found in
the samples of leaves and bark of P. macrocarpa. Tannins
form a class of polyphenolic compounds which can act as
antioxidants, antiviral, antibacterial, antiparasitic, and anti-
inﬂammatory activity [39–42]. During the inﬂammatory
cascade, antioxidants act as scavengers for free radicals
protecting cells against oxidants which are mostly reactive
oxygen and nitrogen species [43–45]. The aforementioned
ﬁndings may justify the traditional medicinal uses of the
P. macrocarpa and C. gigantea and hence there is the need
to perform bioactivity fractionation of the active extracts
to isolate the compounds that may be responsible for the
antimicrobial and anti-inﬂammatory properties.
5. Conclusion
The minimum inhibitory concentration ranges of both
ethanol leaf and bark extracts of P. macrocarpa against the
test organisms were from 0.125 to 2.55mg/mL and those
of C. gigantea extracts were from 0.125 to 2.75mg/mL.
Extracts (10, 25, and 50mg/mL) of P. macrocarpa and C.
giganteaexhibited antimicrobial activity with concentrations
of 50mg/mL showing the highest zones of inhibition against
the test organisms. All the extracts of P. macrocarpa and
C. gigantea at 30, 100, and 300mg/kg except leaf extract of
C. gigantea exhibited signiﬁcant anti-inﬂammatory activity.
The aformentioned activities may conﬁrm the ethnobotan-
ical uses of these two plants as antimicrobial and anti-
inﬂammatory agents. It is recommended that the bioactive8 Evidence-Based Complementary and Alternative Medicine
extracts should be fractionated and the active compounds
responsible for the previous pharmacological properties
should be isolated.
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